# How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics

> **NCT00667732** · PHASE4 · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 41 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** exenatide
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00667732
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2009-10
- **Final completion:** 2010-04
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2013-02-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00667732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00667732, "How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00667732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*